Search results

Multi-million dollar Australian Cancer Research Foundation (ACRF) Detector launched at the Australian Synchrotron,

Clarity Pharmaceuticals is building on comprehensive work on chelators carried out at ANSTO.

The growth and incorporation of graphene into semiconductor device architectures has been limited by challenges related to the quality, reproducibility, and high process temperatures required to grow it on suitable substrates.

The nuclear analysis team at ANSTO recently had a significant role in the re-design and optimisation of a cold neutron source facility for the reactor, its installation and the subsequent restart after a six-month shutdown.

ANSTO is part of collaboration conducting experiments to redefine the kilogram linking it to a fundamental constant of nature.

The Australian Centre for Neutron Scattering (ACNS) is a major research facility for neutron science that comprises a suite of neutron instruments with a range of techniques for scientific investigations in physics, chemistry, materials science, medicine and environmental science among other fields.

Research highlights how biodistribution of a toxic substance essential to understand all exposure risks.